{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:25Z","timestamp":1787509165566,"version":"build-2736575974"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of this survey is to provide a snapshot of current practice regarding antithrombotic therapy (ATT) in patients with atrial fibrillation (AF) comorbid with intracerebral haemorrhage (ICH). An online survey was distributed to members of the European Heart Rhythm Association. A total of 163 clinicians responded, mostly cardiologists or electrophysiologists (87.7%), predominantly working in University hospitals (61.3%). Most respondents (47.2%) had seen one to five patients with AF comorbid with ICH in the last 12 months. Among patients sustaining an ICH on oral anticoagulation (OAC), 84.3% respondents would consider some form of ATT post-ICH, with 73.2% preferring to switch from a vitamin-K antagonist (VKA) to a non-VKA oral anticoagulant (NOAC) and 37.2% preferring to switch from one NOAC to another. Most (36.6%) would restart OAC &amp;gt;30\u2009days post-ICH. Among patients considered unable to take OAC, left atrial appendage occlusion procedure was the therapy of choice in 73.3% respondents. When deciding on ATT, respondents considered patient\u2019s CHA2DS2-VASc score, ICH type, demographics, risk factors, and patient adherence. The main reason for not restarting or commencing ATT was concern about recurrent ICH (80.8%). National or international clinical guidelines would be advantageous to support decision-making (84.3%). Other helpful resources reported were multidisciplinary team involvement (46.9%) and patient education (82%). In summary, most survey respondents would prescribe OAC therapy for patients with AF who have sustained an ICH on OAC and would restart OAC &amp;gt;30\u2009days post-ICH. The risk of recurrent ICH was the main reason for not prescribing any ATT post-ICH.<\/jats:p>","DOI":"10.1093\/europace\/euaa423","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T15:15:42Z","timestamp":1609341342000},"page":"806-814","source":"Crossref","is-referenced-by-count":11,"title":["Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey"],"prefix":"10.1093","volume":"23","author":[{"given":"Elena","family":"Ivany","sequence":"first","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool , 6 West Derby Street, Liverpool L7 8TX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-9378","authenticated-orcid":false,"given":"Deirdre A","family":"Lane","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool , 6 West Derby Street, Liverpool L7 8TX, UK"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University , Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe-Andrei","family":"Dan","sequence":"additional","affiliation":[{"name":"Internal Medicine, Carol Davila\u2019 University of Medicine, Colentina University Hospital \u2018 , Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7598-708X","authenticated-orcid":false,"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies , Berlin, Germany"},{"name":"Department of Cardiology (Virchow Klinikum), Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin , Berlin, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK) , Partner Site Berlin, Berlin, Germany"},{"name":"Center for Stroke Research Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin , Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal M","family":"Farkowski","sequence":"additional","affiliation":[{"name":"II Department of Heart Arrhythmia, National Institute of Cardiology , Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Iliodromitis","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology and Electrophysiology, Evangelisches Krankenhaus Hagen-Haspe , Hagen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Lenarczyk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Congenital Heart Defects and Electrotherapy, Medical University of Silesia, Silesian Center of Heart Disease , Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana S","family":"Potpara","sequence":"additional","affiliation":[{"name":"Serbia School of Medicine, University of Belgrade , Belgrade, Serbia"},{"name":"Department for Intensive Care in Cardiac Arrhythmias, Cardiology Clinic, Clinical Centre of Serbia , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,31]]},"reference":[{"key":"2022090112085219800_euaa423-B1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"2022090112085219800_euaa423-B2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2022090112085219800_euaa423-B3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jns.2019.01.013","article-title":"Intracerebral hemorrhage outcome: a comprehensive update","volume":"398","author":"Pinho","year":"2019","journal-title":"J Neurol Sci"},{"key":"2022090112085219800_euaa423-B4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.69.5.601","article-title":"Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden","volume":"69","author":"Nilsson","year":"2000","journal-title":"J Neurol Neurosurg Psych"},{"key":"2022090112085219800_euaa423-B5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ene.12215","article-title":"Prevalence of atrial fibrillation in intracerebral hemorrhage","volume":"21","author":"Horstmann","year":"2014","journal-title":"Eur J Neurol"},{"key":"2022090112085219800_euaa423-B6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2022090112085219800_euaa423-B7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamainternmed.2016.9369","article-title":"Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation","volume":"177","author":"Nielsen","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2022090112085219800_euaa423-B8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"2022090112085219800_euaa423-B9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5853\/jos.2018.02243","article-title":"Anticoagulants in older patients with nonvalvular atrial fibrillation after intracranial hemorrhage","volume":"21","author":"Perreault","year":"2019","journal-title":"J Stroke"},{"key":"2022090112085219800_euaa423-B10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2396987319841187","article-title":"Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline","volume":"4","author":"Klijn","year":"2019","journal-title":"Eur Stroke J"},{"key":"2022090112085219800_euaa423-B11","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"2022090112085219800_euaa423-B12","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"2022090112085219800_euaa423-B13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1532-5415.2001.49016.x","article-title":"The sin of omission: a systematic review of antithrombotic therapy to prevent stroke in atrial fibrillation: antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"49","author":"Hart","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"2022090112085219800_euaa423-B14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2022090112085219800_euaa423-B15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","article-title":"Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis","volume":"85","author":"Poon","year":"2014","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"2022090112085219800_euaa423-B16","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2019.09.064","article-title":"Long-term safety and efficacy in continued access left atrial appendage closure registries","volume":"74","author":"Holmes","year":"2019","journal-title":"JACC"},{"key":"2022090112085219800_euaa423-B17","first-page":"euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion \u2013 an update","author":"Glikson","year":"2019","journal-title":"Europace"},{"key":"2022090112085219800_euaa423-B18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.08.017","article-title":"Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation","volume":"312","author":"Maeda","year":"2012","journal-title":"J Neurol Sci"},{"key":"2022090112085219800_euaa423-B19","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4022\/jafib.1870","article-title":"What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis","volume":"10","author":"Oqab","year":"2018","journal-title":"J Atrial Fibrillation"},{"key":"2022090112085219800_euaa423-B20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/europace\/euz344","article-title":"Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices","volume":"22","author":"Potpara","year":"2020","journal-title":"Europace"},{"key":"2022090112085219800_euaa423-B21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/europace\/euaa126","article-title":"Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis","volume":"22","author":"Wu","year":"2020","journal-title":"Europace"},{"key":"2022090112085219800_euaa423-B22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cpt.1024","article-title":"Underuse of vitamin K antagonist and direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: a contemporary review","volume":"104","author":"Hsu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"2022090112085219800_euaa423-B23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"2022090112085219800_euaa423-B24","first-page":"1947","article-title":"Integrated care in atrial fibrillation: a systematic review and meta-analysis","volume":"103","author":"Gallagher","year":"2017","journal-title":"Heart"},{"key":"2022090112085219800_euaa423-B25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.amjmed.2019.01.003","article-title":"ABC (atrial fibrillation better care) pathway and healthcare costs in atrial fibrillation: the ATHERO-AF Study","volume":"132","author":"Pastori","year":"2019","journal-title":"Am J Med"},{"key":"2022090112085219800_euaa423-B26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/joa3.12364","article-title":"Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: a nationwide cohort study","volume":"36","author":"Yang","year":"2020","journal-title":"J Arrhythmia"},{"key":"2022090112085219800_euaa423-B27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijcard.2005.07.031","article-title":"Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme: the West Birmingham Atrial Fibrillation Project","volume":"110","author":"Lane","year":"2006","journal-title":"Int J Cardiol"},{"key":"2022090112085219800_euaa423-B28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/1060028019835845","article-title":"Assessment of condition and medication knowledge gaps among atrial fibrillation patients: a systematic review and meta-analysis","volume":"53","author":"Salmasi","year":"2019","journal-title":"Ann Pharmacother"},{"key":"2022090112085219800_euaa423-B29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2377-6-38","article-title":"Perception of stroke and knowledge of potential risk factors among Omani patients at increased risk for stroke","volume":"6","author":"Al Shafaee","year":"2006","journal-title":"BMC Neurol"},{"key":"2022090112085219800_euaa423-B30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.STR.0000209332.96513.82","article-title":"Knowledge about risk factors for stroke","volume":"37","author":"M\u00fcller-Nordhorn","year":"2006","journal-title":"Stroke"},{"key":"2022090112085219800_euaa423-B31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.pec.2019.03.015","article-title":"Impact of adding a video to patient education on quality of life among adults with atrial fibrillation: a randomized controlled trial","volume":"102","author":"Gagn\u00e9","year":"2019","journal-title":"Patient Educ Counsel"},{"key":"2022090112085219800_euaa423-B32","doi-asserted-by":"crossref","first-page":"e74037","DOI":"10.1371\/journal.pone.0074037","article-title":"Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT Randomised Trial","volume":"8","author":"Clarkesmith","year":"2013","journal-title":"PLoS ONE"},{"key":"2022090112085219800_euaa423-B33","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/23\/5\/806\/45639576\/euaa423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/23\/5\/806\/45639576\/euaa423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T09:53:49Z","timestamp":1662026029000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/23\/5\/806\/6124844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,31]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,1,31]]},"published-print":{"date-parts":[[2021,5,21]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaa423","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,1,31]]}}}